Copyright
        ©The Author(s) 2015.
    
    
        World J Gastroenterol. Feb 21, 2015; 21(7): 2096-2101
Published online Feb 21, 2015. doi: 10.3748/wjg.v21.i7.2096
Published online Feb 21, 2015. doi: 10.3748/wjg.v21.i7.2096
		Figure 1 Kaplan-Meier curves of overall survival and progression free survival.
		
			 OS: Overall survival; PFS: Progression-free survival.
		
	
- Citation: Guion-Dusserre JF, Lorgis V, Vincent J, Bengrine L, Ghiringhelli F. FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma. World J Gastroenterol 2015; 21(7): 2096-2101
 - URL: https://www.wjgnet.com/1007-9327/full/v21/i7/2096.htm
 - DOI: https://dx.doi.org/10.3748/wjg.v21.i7.2096
 
